Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1
Victoria Weston(University of Birmingham), Pamela Kearns(National Institute for Health and Care Research)
Cited by 12
Related Papers
The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1
|Blood|2013|90
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement
|British Journal of Cancer|2020|44
The Care of Children With Cancer During the COVID-19 Pandemic
|American Society of Clinical Oncology Educational Book|2021|31
The Global COVID‐19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global
|Pediatric Blood & Cancer|2021|16
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective
|British Journal of Cancer|2022|2